Viking Therapeutics
VKTX
#3884
Rank
NZ$6.01 B
Marketcap
NZ$47.19
Share price
-0.27%
Change (1 day)
-29.28%
Change (1 year)

Earnings for Viking Therapeutics (VKTX)

Earnings in 2026 (TTM): -NZ$1.1 Billion

According to Viking Therapeutics 's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -NZ$0.66 Billion a decrease over its 2024 earnings that were of -NZ$0.2 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Viking Therapeutics from 2014 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$1.1 Billion68.86%
2025 -NZ$0.66 Billion227.05%
2024 -NZ$0.2 Billion28.02%
2023 -NZ$0.16 Billion24.73%
2022 -NZ$0.13 Billion25.24%
2021 -NZ$99.43 Million39.23%
2020 -NZ$71.41 Million53.21%
2019 -NZ$46.61 Million16.84%
2018 -NZ$39.89 Million7.22%
2017 -NZ$37.21 Million39.68%
2016 -NZ$26.64 Million-37.05%
2015 -NZ$42.32 Million6.94%
2014 -NZ$39.57 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Ultragenyx Pharmaceutical
RARE
-NZ$0.81 Billion-28.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
NZ$55.46 M-104.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Recro Pharma
REPH
NZ$6.8 M-100.60%๐Ÿ‡บ๐Ÿ‡ธ USA